Van de Venter M - Search Results

1

Caspase-3 activation and induction of PARP cleavage by cyclic dipeptide cyclo(Phe-Pro) in HT-29 cells.

Brauns SC, Dealtry G, Milne P, Naudé R, Van de Venter M. Brauns SC, et al. Among authors: van de venter m. Anticancer Res. 2005 Nov-Dec;25(6B):4197-202. Anticancer Res. 2005. PMID: 16309216 Free article.

2

The role of microcystin-LR in the induction of apoptosis and oxidative stress in CaCo2 cells.

Botha N, Gehringer MM, Downing TG, van de Venter M, Shephard EG. Botha N, et al. Among authors: van de venter m. Toxicon. 2004 Jan;43(1):85-92. doi: 10.1016/j.toxicon.2003.10.025. Toxicon. 2004. PMID: 15037033

3

Selected cyclic dipeptides inhibit cancer cell growth and induce apoptosis in HT-29 colon cancer cells.

Brauns SC, Milne P, Naudé R, Van de Venter M. Brauns SC, et al. Among authors: van de venter m. Anticancer Res. 2004 May-Jun;24(3a):1713-9. Anticancer Res. 2004. PMID: 15274345 Free article.

4

An investigation into the biological activity of the selected histidine-containing diketopiperazines cyclo(His-Phe) and cyclo(His-Tyr).

McCleland K, Milne PJ, Lucieto FR, Frost C, Brauns SC, Van De Venter M, Du Plessis J, Dyason K. McCleland K, et al. Among authors: van de venter m. J Pharm Pharmacol. 2004 Sep;56(9):1143-53. doi: 10.1211/0022357044139. J Pharm Pharmacol. 2004. PMID: 15324483

5

The biological activity of the histidine-containing diketopiperazines cyclo(His-Ala) and cyclo(His-Gly).

Lucietto FR, Milne PJ, Kilian G, Frost CL, Van De Venter M. Lucietto FR, et al. Among authors: van de venter m. Peptides. 2006 Nov;27(11):2706-14. doi: 10.1016/j.peptides.2006.04.023. Epub 2006 Jun 21. Peptides. 2006. PMID: 16797105

6

The synthesis and anticancer activity of selected diketopiperazines.

van der Merwe E, Huang D, Peterson D, Kilian G, Milne PJ, Van de Venter M, Frost C. van der Merwe E, et al. Among authors: van de venter m. Peptides. 2008 Aug;29(8):1305-11. doi: 10.1016/j.peptides.2008.03.010. Epub 2008 Mar 18. Peptides. 2008. PMID: 18436344

7

Biological inferences from IgM binding characteristics of recombinant human secretory component mutants.

Prinsloo E, Oosthuizen V, Van de Venter M, Naudé RJ. Prinsloo E, et al. Among authors: van de venter m. Immunol Lett. 2009 Jan 29;122(1):94-8. doi: 10.1016/j.imlet.2008.12.004. Epub 2009 Jan 4. Immunol Lett. 2009. PMID: 19126415

8

Sutherlandia frutescens limits the development of insulin resistance by decreasing plasma free fatty acid levels.

MacKenzie J, Koekemoer T, van de Venter M, Dealtry G, Roux S. MacKenzie J, et al. Among authors: van de venter m. Phytother Res. 2009 Nov;23(11):1609-14. doi: 10.1002/ptr.2830. Phytother Res. 2009. PMID: 19370539

9

In vitro anti-HIV activity of five selected South African medicinal plant extracts.

Klos M, van de Venter M, Milne PJ, Traore HN, Meyer D, Oosthuizen V. Klos M, et al. Among authors: van de venter m. J Ethnopharmacol. 2009 Jul 15;124(2):182-8. doi: 10.1016/j.jep.2009.04.043. Epub 2009 May 3. J Ethnopharmacol. 2009. PMID: 19409474

10

Antidiabetic and cytotoxicity screening of five medicinal plants used by traditional African health practitioners in the Nelson Mandela Metropole, South Africa.

van Huyssteen M, Milne PJ, Campbell EE, van de Venter M. van Huyssteen M, et al. Among authors: van de venter m. Afr J Tradit Complement Altern Med. 2011;8(2):150-8. doi: 10.4314/ajtcam.v8i2.63202. Epub 2010 Dec 30. Afr J Tradit Complement Altern Med. 2011. PMID: 22238496 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters